Posted by Michael Wonder on 31 May 2018
New Zealand Pharmaceutical Schedule - 1 June 2018
1 June 2018 - The June 2018 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.
There is one major new listing this month; aflibercept (Eylea) for patients with age-related macular degeneration and macular oedema due to diabetes mellitus.
